0001104659-22-011445.txt : 20220203
0001104659-22-011445.hdr.sgml : 20220203
20220203175836
ACCESSION NUMBER: 0001104659-22-011445
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220201
FILED AS OF DATE: 20220203
DATE AS OF CHANGE: 20220203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Deschamps Lisa
CENTRAL INDEX KEY: 0001847538
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38067
FILM NUMBER: 22589983
MAIL ADDRESS:
STREET 1: C/O VERONA PHARMA PLC
STREET 2: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verona Pharma plc
CENTRAL INDEX KEY: 0001657312
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
BUSINESS PHONE: 011-44-0-2032834200
MAIL ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
4
1
tm225347-5_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-02-01
0
0001657312
Verona Pharma plc
VRNA
0001847538
Deschamps Lisa
3 MORE LONDON RIVERSIDE
LONDON
X0
SE1 2RE
UNITED KINGDOM
1
0
0
0
Ordinary Shares
2022-02-01
4
S
0
11664
0.7775
D
70320
D
Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units.
The price reported represents the sale price of the Issuer's ADSs divided by eight (8).
Consists of 70,320 Ordinary Shares underlying 8,790 ADSs.
/s/ Claire Poll, Attorney-in-fact for Lisa Deschamps
2022-02-03